KB Insurance Launches Exclusive Insurance for Patients with Targeted Anticancer Drug Treatment Costs

KB Insurance announced on the 29th that it will launch a new product exclusively for policyholders with pre-existing conditions, "KB Smart Simple Health Insurance," which is the first in the non-life insurance industry to include targeted anticancer drug approval treatment costs.

[Asia Economy Reporter Oh Hyung-gil] KB Insurance announced on the 29th that it will launch a new product exclusively for policyholders with pre-existing conditions, "KB Smart Simple Health Insurance," which is the first in the non-life insurance industry to include targeted anticancer drug approval treatment costs.

Even if chronic disease patients such as those with hypertension, hyperlipidemia, or diabetes are continuously receiving medication and treatment, they can subscribe at about 80% of the premium compared to existing insurance products for policyholders with pre-existing conditions.

Applicants must not have been hospitalized or undergone surgery within the last 3 years, and must not have been diagnosed with or hospitalized or undergone surgery for any of the 8 major critical illnesses (cancer, leukemia, angina, myocardial infarction, heart valve disease, liver cirrhosis, stroke, AIDS) within the last 5 years.

The product includes targeted anticancer drug approval treatment costs, a cutting-edge cancer treatment method, and also covers lifestyle diseases such as benign tumors, gout, rheumatoid arthritis, and urinary stones, which were not covered by existing insurance for policyholders with pre-existing conditions.

Additionally, with the Pay-Back function for premium waiver, if any of the five major premium waiver reasons occur during the premium payment period (cancer diagnosis, stroke, acute myocardial infarction, disease/injury with over 80% disability), the insured can receive a refund of the premiums already paid, as well as exemption from future premium payments for the coverage.

A KB Insurance official said, "This product was designed with the intention of helping mild chronic disease patients recover their health," and added, "We expect to provide mild policyholders with various options through affordable premiums and differentiated coverage."

This content was produced with the assistance of AI translation services.